BioSpace News Archive

Press Releases

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

August 4, 2026

·

28 min read

Press Releases

Revvity Announces Financial Results for the Second Quarter of 2026

August 4, 2026

·

19 min read

Map location. Businesswoman using laptop to find location vector

IgA nephropathy

Vertex unfazed by competitive IgAN space as FDA verdict looms

Positive two-year follow-up data for Otsuka Pharmaceuticals’ IgA nephropathy drug Voyxact could support the FDA’s ongoing review of Vertex Pharmaceuticals’ povetacicept, CEO Reshma Kewalramani said on the company’s second quarter earnings call.

August 4, 2026

·

2 min read

·

Tristan Manalac

Press Releases

TSRL Receives Second-Year NIH Notice of Award to Advance Microneedle Patch for Overactive Bladder Therapy

August 4, 2026

·

1 min read

Reef knot, Square knot of red and blue rope isolated on white background

Cancer

Pathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamab

Pathos AI could pay more than $2 billion to a Jiangsu Alphamab Biopharmaceuticals subsidiary for a late-stage bispecific antibody-drug conjugate for breast cancer, while the financial details of the AstraZeneca agreement were not disclosed.

August 4, 2026

·

2 min read

·

Tristan Manalac

Press Releases

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

August 4, 2026

·

32 min read

Press Releases

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity